プロリルイソメラーゼは,ドーパミン依存の可塑性およびコカイン運動感受性を媒介する
Joo Min Park1, Jia-Hua Hu, Aleksandr Milshteyn
1Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cell
|August 6, 2013
まとめ
コカイン中毒は,分子イベントによって引き起こされるシナプス変化を伴う. この研究は,特定のシグナル伝達経路とタンパク質がどのように相互作用してシナプス機能を変化させ,マウスの薬物誘発行動につながるかを明らかにしています.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 薬理学 薬理学とは
背景:
- 薬物中毒はシナプス可塑性に関連しています.
- 分子メカニズムを理解することは,治療の開発に不可欠です.
研究 の 目的:
- 薬剤誘発の可塑性を引き起こすシナプスの分子現象を解明する.
- ネズミのコカインに対する行動反応を理解するために.
主な方法:
- D1-ドーパミン受容体のシグナリングを調査した.
- マイクロチューブル関連タンパク質キナーゼ (MAPK) によるメタボトロピックグルタミン酸受容体5 (mGluR5) のリン酸化を試験した.
- mGluR5のプロリルイソメリゼーションにおけるHomer1aとPin1の役割を評価した.
- N-メチル-D-アスパルテート受容体 (NMDAR) 媒介の電流と変異性マウスの運動感受性を研究した.
主要な成果:
- D1-ドーパミン受容体のシグナリングは,MAPKによってmGluR5のリン酸化を誘導する.
- ホーマー1aはPin1-mGluR5の相互作用を可能にし,プロリルイソメリゼーションを活性化します.
- これらのイベントは,NMDAR電流を強化し,シナプス可塑性の基礎であり,コカインによって誘発される運動感受性を高めます.
- 発見は,mGluR5.5の調節における核信号とシナプス信号の一致を強調しています.
結論:
- この研究は,コカインによって誘発されるシナプス可塑性の分子経路を明らかにしています.
- コルチコストリアタルシナプスの脱力化は,中毒治療の潜在的な治療目標として特定されています.
さらに関連する動画
10:28Assessment of Cocaine-induced Behavioral Sensitization and Conditioned Place Preference in Mice
Published on: February 18, 2016
08:22Stereotaxic Microinjection of Viral Vectors Expressing Cre Recombinase to Study the Role of Target Genes in Cocaine Conditioned Place Preference
Published on: July 30, 2013
関連する概念動画
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...